Moderna MRNA
NASDAQ MRNA
$218.00 -18.50 (-7.82%)
As of: Oct 16, 2026 · 3:59 PM EDT

Moderna (MRNA) Debt Ratio (2025 - 2026)

Updated

Moderna's (MRNA) Debt Ratio stood at 0.05 in Q2 2026, up 5.0% from the prior quarter.

Analysis

Moderna (MRNA) Debt Ratio (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 0.39
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 0.24
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 0.52
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn 0.42
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 0.08
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 0.28
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 0.60
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn 0.53
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn 0.31
10 Moderna 85.93 Bn 65.29 Bn 52.00 Mn 0.05
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.05
Mar 31, 2026 0.05
Dec 31, 2025 0.05
API Access

Moderna Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=MRNA&period=max&api_key=YOUR_API_KEY